Gemtuzumab and platelet count decreased Patient Reports February 13, 2012

Gemtuzumab Side Effects Report #5035412-9
Gemtuzumab side effect was reported by a Consumer or non-health professional from POLAND on June 09, 2006. Female patient, 23 years of age, was diagnosed with myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: atelectasis, condition aggravated, fibrin d dimer increased, haemoglobin decreased, hepatomegaly, hyperbilirubinaemia, platelet count decreased, pneumonia , pseudomonal sepsis. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, CANCIDAS, FENTANYL TRANSDERMAL SYSTEM, AMIKIN. Patient recovered.

Gemtuzumab Side Effects Report #4595660-9
Gemtuzumab side effect was reported by a Consumer or non-health professional from on Feb 21, 2005. Male patient, 41 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: balanoposthitis, neutrophil count decreased, platelet count decreased, pseudomonas infection, staphylococcal sepsis. Gemtuzumab dosage: 10.2 MG 1X PER 1 DAY. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4627386-7
Gemtuzumab side effect was reported by a Health Professional from on Mar 17, 2005. Male patient, 41 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: balanoposthitis, culture urine positive, platelet count decreased, pseudomonas infection, staphylococcal sepsis, white blood cell count increased. Gemtuzumab dosage: 10.2 MG 1X PER 1 DAY. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4677726-8
Gemtuzumab side effect was reported by a Consumer or non-health professional from on May 18, 2005. Male patient, 41 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: balanoposthitis, culture positive, haemoglobin decreased, platelet count decreased, staphylococcal sepsis, urinary tract infection pseudomonal, white blood cell count decreased. Gemtuzumab dosage: 10.2 MG 1X PER 1 DAY. Patient was hospitalized. Patient recovered.


Gemtuzumab Side Effects Report #4680268-7
Gemtuzumab side effect was reported by a Consumer or non-health professional from on May 19, 2005. Male patient, 41 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: balanoposthitis, haemoglobin decreased, neutropenia, platelet count decreased, pseudomonas infection, staphylococcal sepsis. Gemtuzumab dosage: 10.2 MG 1X PER 1 DAY. During the same period patient was treated with FEXOFENADINE, ESOMEPRAZOLE, MAGALDRATE, DEXAMETHASONE, CHLORPHENAMINE, ONDANSETRON, ELECTROLYTE SOLUTIONS, BICARBONATE IN PLASTIC CONTAINER. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4746699-1
Gemtuzumab side effect was reported by a Health Professional from ITALY on Aug 04, 2005. Male patient, 41 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: balanoposthitis, culture urine positive, neutropenia, platelet count decreased, pseudomonas infection, staphylococcal sepsis. Gemtuzumab dosage: 10.2 MG 1X PER 1 DAY; SECOND DOSE. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, FEXOFENAIDNE, ESOMEPRAZOLE, MAGALDRATE, DEXAMETHASONE, CHLORPHENAMINE, ONDANSETRON, ELECTROLYTE SOLUTOINS. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #5020474-5
Gemtuzumab side effect was reported by a Consumer or non-health professional from BELGIUM on May 24, 2006. Female patient, 27 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: blast cells present, blood urea increased, haematocrit decreased, haemoglobin decreased, monocyte count increased, neutrophil count decreased, platelet count decreased, red blood cell count decreased, venoocclusive liver disease. Gemtuzumab dosage: 14, 9 MG INTRAVENOUS. During the same period patient was treated with OMEPRAZOLE, FLUCONAZOLE, ACYCLOVIR, TARIVID, MAGNESIUM, FOLIC ACID, LYNESTRENOL, FRAXIPARINE. Patient died.

Gemtuzumab Side Effects Report #5090814-X
Gemtuzumab side effect was reported by a Consumer or non-health professional from TAIWAN, PROVINCE OF CHINA on Aug 10, 2006. Female patient, 69 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: haemorrhage intracranial, platelet count decreased, white blood cell count decreased. Gemtuzumab dosage: 5 MG 1X PER 2 WK INTRAVENOUS. During the same period patient was treated with BICARBONATE IN PLASTIC CONTAINER, ALLOPURINOL, ALLERMIN. Patient died.

Gemtuzumab Side Effects Report #4911220-1
Gemtuzumab side effect was reported by a Consumer or non-health professional from SPAIN on June 28, 2001. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: blood potassium decreased, catheter related infection, haemoglobin decreased, neutropenia, platelet count decreased, post procedural complication, staphylococcal infection . Gemtuzumab dosage: 6 MG/M^2 1X PER 1 DOS INTRAVENOUS. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient was hospitalized. Patient recovered.


Gemtuzumab Side Effects Report #4906851-9
Gemtuzumab side effect was reported by a Consumer or non-health professional from ITALY on Jan 27, 2006. Female patient, 63 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: haemoglobin decreased, lung infection, platelet count decreased, red blood cell count increased, respiratory failure, staphylococcal infection . Gemtuzumab dosage: unknown. Patient died.

Gemtuzumab Side Effects Report #4911214-6
Gemtuzumab side effect was reported by a Consumer or non-health professional from AUSTRIA on Jan 22, 2004. Male patient, 62 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: arthritis , blood creatinine increased, platelet count decreased, retinal haemorrhage, visual acuity reduced. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, CYTARABINE, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4914117-6
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 09, 2002. Female patient, 33 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutropenia, platelet count decreased, pyrexia, tooth abscess. Gemtuzumab dosage: 9 MG/^2 1X PER 1 DOS. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4867028-9
Gemtuzumab side effect was reported by a Health Professional from FRANCE on Oct 28, 1999. Male patient, 26 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: eosinophil percentage increased, leukopenia, lymphocyte percentage increased, nausea , neutropenia, platelet count decreased, pyrexia. Gemtuzumab dosage: 9 MG/M (2) (TOTAL DOSE: 16 MG/DOSE) INTRAVENOUS 2 DOS. During the same period patient was treated with SPORANOX, ANZEMET, PLITICAN, POLARAMINE. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #5055223-8
Gemtuzumab side effect was reported by a Consumer or non-health professional from ITALY on July 03, 2006. Female patient, 63 years of age, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: blood ph increased, haemoglobin decreased, lung infection, platelet count decreased, red blood cell count decreased, respiratory failure, staphylococcal infection . Gemtuzumab dosage: 10 MG. During the same period patient was treated with CYTARABINE, ETOPOSIDE, NOVANTRONE, LEVOFLOXACIN. Patient died.


Gemtuzumab Side Effects Report #5258283-4
Gemtuzumab side effect was reported by a Physician from BELGIUM on Mar 02, 2007. Female patient, 44 years of age, weighting 102.5 lb, was diagnosed with antifungal prophylaxis and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, coma, lymphocyte percentage increased, neutrophil percentage decreased, platelet count decreased, white blood cell count decreased. Gemtuzumab dosage: unknown. During the same period patient was treated with TPN ELECTROLYTES IN PLASTIC CONTAINER, DIFLUCAN, LARGACTIL, IDARUBICIN, CYTARABINE. Patient died on 04/16/2006.

Gemtuzumab Side Effects Report #5950511-2
Gemtuzumab side effect was reported by a Physician from UNITED KINGDOM on Nov 11, 2008. Male patient was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: platelet count decreased, subdural haemorrhage. Gemtuzumab dosage: unknown. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient was hospitalized. Patient died on 01/01/2008.

Gemtuzumab Side Effects Report #5960178-5
Gemtuzumab side effect was reported by a Physician from UNITED KINGDOM on Nov 19, 2008. Male patient was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: platelet count decreased, subdural haemorrhage. Gemtuzumab dosage: unknown. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient was hospitalized. Patient died on 08/27/2008.